Logo 871 (Glipizide extended release 2.5 mg)
Pill imprint Logo 871 has been identified as Glipizide extended release 2.5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for Logo 871 (Glipizide extended release 2.5 mg)
More about glipizide
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...